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Laminin γ1 C-terminal Glu to Gln mutation induces early
postimplantation lethality
Daiji Kiyozumi1 , Yukimasa Taniguchi1, Itsuko Nakano1, Junko Toga1, Emiko Yagi1, Hidetoshi Hasuwa2, Masahito Ikawa2,
Kiyotoshi Sekiguchi1
Laminin–integrin interactions regulate various adhesion-
dependent cellular processes. γ1C-Glu, the Glu residue in the
laminin γ1 chain C-terminal tail, is crucial for the binding of
γ1-laminins to several integrin isoforms. Here, we investigated
the impact of γ1C Glu to Gln mutation on γ1-laminin binding to all
possible integrin partners in vitro, and found that the mutation
specifically ablated binding to α3, α6, and α7 integrins. To ex-
amine the physiological significance of γ1C-Glu, we generated
a knock-in allele, Lamc1EQ, in which the γ1C Glu to Gln mutation
was introduced. Although Lamc1EQ/EQ homozygotes developed
into blastocysts and deposited laminins in their basement
membranes, they died just after implantation because of dis-
ordered extraembryonic development. Given the impact of the
Lamc1EQ allele on embryonic development, we developed
a knock-in mouse strain enabling on-demand introduction of the
γ1C Glu to Glnmutation by the Cre-loxP system. The present study
has revealed a crucial role of γ1C-Glu–mediated integrin binding
in postimplantation development and provides useful animal
models for investigating the physiological roles of laminin–
integrin interactions in vivo.
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Introduction
Laminins, αβγ trimeric glycoproteins, are major components of
basement membranes (BMs) that play crucial roles in transmitting
BM signals to cells. Various cellular processes including adhesion,
migration, survival, proliferation, and differentiation are supported
by laminins through interactions with cell-surface receptors. The
most important receptors for sensing laminin signals are integrins,
which are αβ dimeric cell-surface transmembrane proteins.
There are several modes of laminin–integrin interactions. One of
the integrin-binding sites in laminins is located in a C-terminal αβγ
complex known as the E8 fragment (Sonnenberg et al, 1990). The E8
fragments of laminins interact with multiple integrins, including
α3β1, α6β1, α6β4, and α7β1 (Sonnenberg et al, 1990; Ido et al, 2007;
Taniguchi et al, 2009). It is known that αβγ trimer formation, LG1–3
domains of the α chain, and Glu residue in the γ1 chain C-terminal
tail (γ1C-Glu) (Fig 1A) are prerequisites for the integrin-binding
ability of E8 fragments (Sung et al, 1993; Ido et al, 2004, 2007;
Taniguchi et al, 2017). Recently, the crystal structures of truncated
E8 fragments derived from laminin-111 and laminin-511 were solved
(Pulido et al, 2017; Takizawa et al, 2017). The structures predicted
that γ1C-Glu can bind directly to themetal ion-dependent adhesion
site in the integrin β1 subunit. Thus, the biochemical significance of
γ1C-Glu for integrin binding is apparent, but its physiological roles
remain to be fully addressed.
Here, we investigated the physiological significance of γ1C-Glu
for laminin–integrin interactions in vivo by generating a knock-in
mouse strain in which γ1C-Glu was substituted with Gln. The
resulting knock-in mice showed early postimplantation lethality,
underscoring the critical role of γ1C-Glu–dependent laminin–
integrin interactions for early embryonic development. Based on
these findings, we established another knock-in mouse strain in
which the γ1C Glu to Gln (EQ) mutation can be introduced on
demand by the Cre-loxP system.
Results and Discussion
γ1 EQ mutation specifically abolishes laminin binding to α3, α6,
and α7 integrins in vitro
Before starting in vivo studies, we confirmed the impact of γ1C-Glu
on integrin binding by laminins in vitro (Fig 1). For this, we expressed
and purified recombinant full-length laminin-111 and laminin-511
and their derivatives containing the EQ mutation (Fig S1). Because
a panel of integrins including α1β1, α2β1, α3β1, α6β1, α6β4, α7β1,
α9β1, αvβ3, and αvβ5 were reported to interact with these laminins
(Forsberg et al, 1994; Pfaff et al, 1994; Sasaki & Timpl, 2001; Nishiuchi
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et al, 2006), we expressed these integrins as truncated soluble
forms in mammalian cells. Integrin α5β1 was also included as
a negative control. The recombinant integrins were assessed for
their abilities to bind to the laminins and their EQmutants by solid-
phase binding assays (Ido et al, 2007) (Figs 1B–M and S2A).
Integrins α3β1, α6β1, α6β4, and α7x1β1 bound specifically to
laminin-511, whereas integrin α7x2β1 bound to both laminin-111
and laminin-511 (Fig 1D–H). Integrin α6β1 binding to recombinant
laminin-111 was weak under the used condition (Fig 1E), unlike in
previous reports that used Engelbreth-Holm-Swarm (EHS) tumor-
derived mouse laminin-111 (Sonnenberg et al, 1990; Nishiuchi et al,
2003, 2006). When the coating concentration of laminin-111 was
increased, integrin α6β1 was capable of binding to both mouse and
human laminin-111 in a dose-dependent manner, but mouse
laminin-111 had significantly more affinity than human recombi-
nant laminin-111 for integrin α6β1 (Fig S2B). Introduction of the γ1
EQ mutation abolished the abilities of laminin-111 and laminin-511
to bind to these integrins, consistent with our previous reports (Ido
et al, 2007; Taniguchi et al, 2009). Among the other integrins ex-
amined, two Arg-Gly-Asp (RGD)-binding integrins, αvβ3 and αvβ5,
exhibited significant binding to laminin-511 and weaker binding to
laminin-111, and this binding was not compromised by the γ1 EQ
mutation (Fig 1J and K). No binding to integrins α1β1, α2β1, α9β1, and
α5β1 was observed (Figs 1B, C, I, L and S2A). This comprehensive
survey of the integrin-binding activities of full-length laminin-111
and laminin-511 and their EQ mutants clearly showed that γ1
Figure 1. Binding of recombinant laminin-111,
laminin-511, and their EQ mutants to integrins.
(A) Schematic diagram of a full-length laminin. The Glu
(E) residue in the C-terminal region of the γ1 chain
critical for integrin binding is indicated. (B–L) Binding of
recombinant integrin α1β1 (B), α2β1 (C), α3β1 (D), α6β1
(E), α6β4 (F), α7x1β1 (G), α7x2β1 (H), α9β1 (I), αvβ3 (J),
αvβ5 (K), and α5β1 (L) to immobilized laminins (LMs),
type-I and type-IV collagens, polydom, and vitronectin.
(M) Anti-FLAG antibody binding for quantification of
immobilized recombinant proteins. Vertical axes
represent absorbance at 490 nm which indicates
integrin binding. Data represent means ± SD of
triplicate assays.
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laminins were susceptible to the γ1 EQ mutation for their in-
teractions with classical laminin-binding integrins, that is, α3β1,
α6β1, α6β4, and α7β1.
Generation of Lamc1EQ mice and embryonic lethality
To evaluate the impact of the γ1 EQ mutation in vivo, we generated
a γ1 EQ knock-in allele, Lamc1EQ, in which the codon encoding γ1C-
Glu wasmutated to introduce Gln (Fig 2A and B). Although Lamc1EQ/+
heterozygous mice were fertile and did not exhibit any develop-
mental defects, no Lamc1EQ/EQ neonates were obtained (Fig 2C).
Because αβγ trimer formation is a prerequisite for efficient
secretion of laminins (Yurchenco et al, 1997), we examined whether
laminins formed αβγ trimers in Lamc1EQ/EQ mice. Protein extracts
from Lamc1EQ/EQ E7.5 embryos were subjected to SDS–PAGE under
nonreducing conditions and immunoblotted with an anti-laminin
antibody. Lamc1EQ/EQ embryonic extracts produced a signal at ~800
kD similar to the case for Matrigel, a laminin-111–rich mouse tumor
extract (Fig 2D). These results confirmed that EQ mutant laminins
were able to form αβγ trimers. To address whether both laminin-111
and laminin-511 with a mutated γ1 chain can be secreted normally,
we expressed these laminins in human 293 cells, and conditioned
media were subjected to SDS–PAGE under non-reducing conditions
and subsequent immunoblotting. No significant difference was
detected in the amounts of the secreted heterotrimers between
laminin-111/-511 and their EQ-mutants (Fig S3), suggesting that
laminin-111 and laminin-511 with the mutated γ1 chain were se-
creted normally. Therefore, Lamc1EQ/EQ mice were phenotypically
Figure 2. Generation of Lamc1EQ/EQ knock-in mice.
(A) Schematic diagram of the targeted mutation of
Lamc1. The open boxes represent exons. The knock-in
construct was designed to replace WT exon 28
encoding Glu at residue 1,605 with a mutant exon 28
encoding Gln at residue 1,605. The probes used for
Southern blotting are indicated by bold lines. (B)
Southern blot analyses of genomic DNA from WT,
Lamc1EQ(neo)/+, and Lamc1EQ/+ offspring after digestion
with SexAI and PacI. The detection of 9.0- and 7.4-kbp
fragments with probe 1 and probe 2, respectively, in the
Lamc1EQ(neo)/+ lanes indicates the occurrence of the
expected homologous recombination. The detection of
a 7.4-kbp fragment with probe 1 in the Lamc1EQ/+ lane
indicates that the neomycin-resistance gene has been
removed from the Lamc1EQ(neo) allele by the Cre-loxP
system. (C) Survival of WT, Lamc1EQ/+, and Lamc1EQ/EQ
littermates obtained from Lamc1EQ/+ intercrosses. (D)
Western analyses of a protein extract from a Lamc1EQ/EQ
E7.5 whole embryo and Matrigel using an anti-laminin
antibody under nonreducing conditions. (E, F) In situ
binding of recombinant integrin α7x2β1 (green) in E7.5
WT or Lamc1EQ/+ (E) and Lamc1EQ/EQ (F) frozen sections.
The RM was counterstained with an anti–laminin-α1
mAb (magenta). Bars, 100 μm. (G, H) Light microscopic
images of control Lamc1EQ/+ (G) and Lamc1EQ/EQ (H)
E7.5 whole embryos. The filled arrowhead indicates the
PYS. The open arrowheads indicate trophoblast giant
cells. Bars, 200 μm. (I–K) Immunofluorescence staining
for cytokeratin-8 (magenta) and laminin (green) in
WT or Lamc1EQ/+ (I) and Lamc1EQ/EQ (J, K) E7.5 sections.
Blue, nuclei. The boxed area in J is magnified in K.
The open diamonds in I indicate the blood sinus. The
asterisks in I and J indicate trophoblast giant cells.
The arrowheads in K indicate the extracellular matrix
structure. Bars, 100 μm. Amn, amnion; Ch, chorion;
ExE, extraembryonic ectoderm; Epi, epiblast; S, SexAI
restriction site; P, PacI restriction site; TK, thymidine
kinase gene; EPC, ectoplacental cone; EC, egg cylinder;
PYS, parietal yolk sac.
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different from Lamc1−/− mice (Smyth et al, 1999), because they
expressed αβγ trimeric laminin, whereas Lamc1−/− mice did not.
When E7.5 embryo sections were examined for binding of integrin
α7x2β1, which can bind both laminin-111 and laminin-511 (Fig 1H),
WT and Lamc1EQ/+ embryos showed specific integrin α7x2β1 binding
in their laminin-positive BMs (Fig 2E). Lamc1EQ/EQ homozygotes were
distinguished from the other embryos by the absence of this
integrin binding (Fig 2F). These results demonstrated that the γ1C-
Glu–dependent integrin-binding activity of laminins was abolished
by the γ1 EQ mutation in vivo.
To address the embryonic lethality of Lamc1EQ/EQ mice, E7.5 egg
cylinders were investigated morphologically by light microscopy
or sectioned and examined by immunofluorescence. Because
laminin-111 and laminin-511 are expressed in Reichert’s membrane
(RM) (Sasaki et al, 2002; Miner et al, 2004), the parietal yolk sac, an
extraembryonic tissue enveloping the egg cylinder, was visualized
by its laminin-positive BM in sections of control WT/Lamc1EQ/+
embryos (Fig 2G and I). However, a parietal sac was not observed in
Lamc1EQ/EQ homozygotes, although laminin was expressed (Fig 2H, J,
and K). Trophoblast giant cells, which are cytokeratin-8–positive
and have large nuclei, were recognized in both WT/Lamc1EQ/+ and
Lamc1EQ/EQ embryos (Fig 2I and J), suggesting that extraembryonic
cell differentiation was not affected in Lamc1EQ/EQ homozygotes.
Collectively, Lamc1EQ/EQmice showed morphogenetic defects at the
early postimplantation stage.
γ1C-Glu–dependent integrin binding is dispensable for BM
deposition
To determine the timing for the morphological abnormality in
Lamc1EQ/EQ homozygotes, we investigated the development of
preimplantation embryos. Before implantation (E4.0 and E4.3),
formation of the blastocoel cavity and inner cell mass were
comparable between WT and Lamc1EQ/EQ blastocysts (Fig 3A–H). At
E4.0, laminins were barely detected at the basal surface of the
mural trophectoderm in blastocysts, irrespective of the genotypes
(Fig 3A–D). Similarly, perlecan, another BM component, was not
detected in E4.0 blastocysts (Fig 3A and B). In E4.3 blastocysts,
laminins were detected at the basal surface of the mural tro-
phectoderm in both WT and Lamc1EQ/EQ blastocysts (Fig 3E–H).
Perlecan was also detected at the basal aspect of the mural tro-
phectoderm in E4.3 blastocysts (Fig 3E and F). Primitive endoderm
cells, the main laminin-producing cells producing dense signals
with an anti-laminin antibody, were recognized in both WT and
Lamc1EQ/EQ blastocysts (asterisks in Fig 3E–H). The laminin-binding
integrin α6 was localized at the basal surface of the mural tro-
phectoderm in WT and Lamc1EQ/EQ blastocysts irrespective of the
laminin deposition in E4.0 (Fig 3C and D) and E4.3 (Fig 3G and H)
blastocysts. To further examine the BM development in blastocysts,
E3.5 blastocysts were flushed out from the uterus and cultured
ex vivo for 48 h. In both ex vivo-cultured Lamc1EQ/+ and Lamc1EQ/EQ
blastocysts, laminins were densely deposited at the basal surface
of the mural trophectoderm, where another BM component, per-
lecan, was colocalized (Fig 3I and J). These findings indicate that the
preimplantation development of Lamc1EQ/EQ embryos was normal
according to their morphology, laminin deposition, and BM for-
mation. It has been reported that deficiency of BM formation in
embryoid bodies derived from β1 integrin-null mouse embryonic
stem (ES) cells (Aumailley et al, 2000; Li et al, 2002) can be rescued
by exogenous addition of laminin-111 in vitro (Li et al, 2002). Be-
cause the BM assembly rescued by exogenous laminin-111 was
blocked by the addition of the E3 fragment of laminin-111, but not
the E8 fragment, E3-binding non-integrin receptors (e.g., dystro-
glycan, syndecan, and sulfated glycolipids) play dominant roles in
the BM assembly of laminins. The dispensability of integrin binding
of laminins in BM formation shown here using ex vivo-cultured
Lamc1EQ/EQ blastocysts is consistent with these previous findings.
Nevertheless, we cannot exclude the possibility that γ1 EQmutation
affects the BM assembly of laminins, which is not discernible at the
level of conventional histology, thereby contributing to the phe-
notype of Lamc1EQ/EQ embryos.
Because no apparent abnormalities in morphology and laminin
deposition were observed in the Lamc1EQ/EQ blastocysts, we in-
vestigated the early postimplantation development at E5.5 by
immunofluorescence (Fig 3K–O). Expression of Oct4 and Cdx2,
markers for the epiblast and extraembryonic ectoderm, respec-
tively, was detected in Lamc1EQ/EQ embryos and in the control WT/
Lamc1EQ/+ littermates (Fig 3M and N). Visceral endoderm and pa-
rietal endoderm cells were also observed in Lamc1EQ/EQ sections
(Fig 3O). Thus, both embryonic and extraembryonic cell fate de-
cisions occurred in Lamc1EQ/EQ embryos. RM, which was stained
with an anti-laminin-α1 antibody, was formed in control WT and
Lamc1EQ/+ heterozygotes at E5.5 (Fig 3K). RM was also formed in
Lamc1EQ/EQ homozygotes at E5.5 (Fig 3L), but showed severe dis-
organization by E7.5 (Fig 2J and K). These findings indicate that RM
formation was not affected in Lamc1EQ/EQ mice until at least E5.5. It
was previously shown in vivo that RM formation requires α1-con-
taining laminins and dystroglycan (Williamson et al, 1997; Miner
et al, 2004). However, the deficient RM formation observed in
Lamc1EQ/EQ mice was different from that in laminin-α1 or dystro-
glycan knockout mice because the RM was initially formed in
Lamc1EQ/EQ mice.
γ1C-Glu–dependent integrin binding is indispensable for
postimplantation development of extraembryonic tissues
Although cell differentiation and BM formation appeared un-
affected at E5.5, Lamc1EQ/EQ embryos were smaller than control WT/
Lamc1EQ/+ embryos (Fig 3M and N) and exhibited poor development
of extraembryonic tissues. The parietal yolk sac in Lamc1EQ/EQ
embryos also appeared smaller than that in WT/Lamc1EQ/+ embryos
(Fig 3M and N). Therefore, we investigated the development of the
parietal yolk sac by measuring the RM length on sections by
quantitative image analysis (Fig 3P and Q). After implantation at
E5.5, the parietal yolk sac in WT and Lamc1EQ/+ zygotes grew ex-
pansively and the RM length reached 452 ± 83 μm when measured
on sections. By contrast, the RM length in Lamc1EQ/EQ homozygotes
was 217 ± 41 μm at E5.5, being significantly smaller than that in
control embryos. These findings clearly showed that the expansive
growth of the parietal yolk sac was defective in Lamc1EQ/EQ ho-
mozygotes. Interestingly, the extraembryonic ectoderm was dis-
sociated from its BM in Lamc1EQ/EQ E5.5 zygotes (Fig 3N), whereas
that in the control WT/Lamc1EQ/+ zygotes was tightly associated
with the BM (Fig 3M). The embryonic part of Lamc1EQ/EQ embryos
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Figure 3. BM formation in Lamc1EQ/EQ zygotes.
(A–H) Whole-mount immunostaining of WT (A, C, E, G) and Lamc1EQ/EQ (B, D, F, H) blastocysts of E4.0 (A–D) and E4.3 (E–H) embryos. The asterisks indicate primitive endoderm
cells. (I, J)Whole-mount immunostaining of E3.5 Lamc1EQ/+ (I) and Lamc1EQ/EQ (J) blastocysts cultured ex vivo for 48 h. Magenta, laminin; green, perlecan (A, B, E, F, I, J) or integrin
α6 (C, D, G, H); blue, nuclei. Bars, 50 μm. The genotypes of the preimplantation embryos were determined by genomic PCR. (K, L) In situ binding of integrin α7x2β1 (green) to E5.5
embryonic sections. The RM was counterstained with an anti-laminin-α1 mAb (magenta). Blue, nuclei. (M, N) Immunofluorescence staining for laminin-α1 (cyan), Cdx2
(magenta), and Oct3 (green) in WT or Lamc1EQ/+ (M) and Lamc1EQ/EQ (N) E5.5 sections. The dashed lines indicate the region where extraembryonic ectoderm cells are associated
with the BM. The open arrowheads indicate extraembryonic ectoderm cells dissociated from the BM. (O) Immunofluorescence staining for laminin (cyan) and laminin-α5
(green) in Lamc1EQ/EQ E5.5 sections. Blue, nuclei. The asterisks and open triangles indicate visceral endoderm cells and parietal endoderm cells, respectively. The arrowheads
indicate the laminin-α5–positive epiblast BM. Bars, 50 μm. (P) Summary of the strategy for quantitative image analysis of RM length in the E5.5 egg cylinder. The RM length
(double-headed arrow) was measured by image tracing. (Q) RM lengths measured in E5.5 Lamc1EQ/EQ embryos and control WT or Lamc1EQ/+ embryos. Data represent means ±
SD. ***P < 0.001, significant difference by Welch’s t test. The effect size was 3.13 and the statistical power was 1.0. ExE, extraembryonic ectoderm; Epi, epiblast.
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was not critically affected, as the epiblast and visceral endoderm
remained associated with their laminin-α5–positive BMs (Fig 3O).
These results indicated that postimplantation development of
extraembryonic tissues was critically dependent on laminin–
integrin interactions through γ1C-Glu. No single α3, α6, or α7
integrin knockout mice were reported to exhibit early post-
implantation defects (Georges-Labouesse et al, 1996; Kreidberg
et al, 1996; Flintoff-Dye et al, 2005). Because integrin α3 and α6
are dispensable for early postimplantation development, as shown
by α3, α6 double-knockout mice (De Arcangelis et al, 1999) early
postimplantation development is probably secured by cooperative
functioning of α7 integrin with α3 and/or α6 integrins. It is,
therefore, likely that integrin α7 functions cooperatively with α3
and/or α6 integrins in extraembryonic tissues because integrin α7
is expressed in the trophectoderm-derived extraembryonic tissues
(Klaffky et al, 2001).
Conditional γ1 EQ knock-in mice as a tool for investigating the
roles of laminin–integrin interactions in adult tissues
The above results clearly showed that the Lamc1EQ knock-in allele is
a valuable tool for investigating the roles of laminin–integrin in-
teractions in vivo, although homozygotes die at the early post-
implantation stage. Based on these results, we tried to develop
a conditional knock-in mouse strain in which γ1C-Glu–dependent
integrin binding can be ablated on demand. By homologous re-
combination in ES cells, we generated another Lamc1 mutant
allele, Lamc1cEQ, in which exon 28 was floxed and an additional EQ-
mutated exon 28 was located in its 39 downstream (Fig 4A and B).
Lamc1cEQ/cEQ homozygous mice were obtained according to the
expected Mendelian ratio (Fig 4C) and appeared healthy and
fertile.
Because the γ1 EQ knock-in mice showed embryonic lethality at
the early developmental stage (Fig 2C), we determined whether
tissue-specific ablation of γ1C-Glu–dependent laminin–integrin
interactions is available while preventing embryonic lethality. We
introduced the Tie2-cre transgene (Kisanuki et al, 2001), expressing
Cre recombinase in an endothelial cell-specific manner, into the
Lamc1cEQ/cEQ genetic background, and examined whether integrin
binding to laminins was ablated in blood vessels. When adult
retinal sections were probed with recombinant integrin α3β1,
recombinant integrin binding to blood vessel BMs was observed in
control Lamc1cEQ/cEQ mice (Fig 4D–F), but not in Tie2-cre;Lamc1cEQ/
cEQ mice (Fig 4G–I), consistent with blood vessel–specific in-
troduction of the γ1 EQ mutation. As Tie2-cre;Lamc1cEQ/cEQ mice
were obtained according to the expected Mendelian ratio (Fig 4J),
conditional ablation of γ1C-Glu–dependent laminin–integrin binding
in vivo was shown to be feasible.
Here, we have revealed the significance of γ1C-Glu in the in-
teractions of laminins with α3, α6, and α7 integrins by in vitro
binding assays and by generating γ1 EQ knock-in mice. We have
further developed a conditional γ1 EQ knock-in system in mice.
Although laminin–integrin interactions have been extensively
studied by in vitro analyses at the molecular and/or cellular levels,
it has been difficult to verify the in vitro results in vivo. Our con-
ditional γ1 EQ knock-in system in mice will be a valuable tool for
investigating the roles of laminin–integrin interactions in various
physiological and pathological situations in vivo.
Materials and Methods
Antibodies and reagents
Rat monoclonal antibodies (mAbs) against mouse laminin α1 (5B7-
H1) and α5 (M5N8-C8) were produced as described (Manabe et al,
2008). Mouse mAbs against human laminin α1 (5A3), α5 (15H5), β1
(DG10), and γ1 (C12SW) were produced as described previously
(Kikkawa et al, 1998; Ido et al, 2007). Mouse mAbs against human
laminin β1 were purchased from Enzo Life Sciences. Rabbit poly-
clonal antibody (pAb) against Velcro (ACID/BASE coiled-coil)
peptides was produced as described (Takagi et al, 2001). Mouse
anti-FLAG mAb, rabbit anti-laminin pAb, and BSA were obtained
from Sigma-Aldrich; rat anti-perlecan mAb was purchased from
Merck Millipore; rat anti-mouse integrin-α6 mAb (GoH3) was from
BD Biosciences; mouse anti-Cdx2 mAb was from Biocare; rabbit
anti-Oct4 pAb was from Santa Cruz Biotechnology; HRP-conjugated
donkey anti-mouse IgG and Cy3-conjugated anti-rat IgG were from
Jackson ImmunoResearch; Alexa 488-conjugated goat anti-rabbit
IgG, Alexa 546-conjugated goat anti-rat IgG, Alexa 405-conjugated
goat anti-rabbit IgG, Alexa 488-conjugated goat anti-rat IgG, and
Alexa 546-conjugated goat anti-mouse IgG were from Invitrogen;
HRP-conjugated streptavidin was from Thermo Fisher Scientific. Rat
anti-cytokeratin-8 mAb (TROMA-I), developed by Philippe Brulet
and Rolf Kemler, was obtained from the Developmental Studies
Hybridoma Bank. The antibody dilutions used are shown in Table
S1. Bovine type I and type IV collagens were obtained fromNippi Inc.
Mouse laminin-111 was prepared from mouse Engelbreth-Holm-
Swarm tumor as described previously (Nishiuchi et al, 2006). Fi-
bronectin was purified from human plasma by gelatin affinity
chromatography as described previously (Sekiguchi & Hakomori,
1983).
Expression vectors
Expression vectors for human laminin α1, α5, β1, and FLAG-tagged γ1
chains were prepared as described (Hayashi et al, 2002; Ido et al,
2004, 2006, 2008). The FLAG tag of laminin γ1 was located just after
the N-terminal signal peptide cleavage site to facilitate purification
of recombinant laminins. Expression vectors for the extracellular
domains of the human integrin α1, α2, α3, α6, α7x1, α7x2, and α9
subunits were constructed as described (Nishiuchi et al, 2006; Sato-
Nishiuchi et al, 2012; Jeong et al, 2013). Expression vectors for the
extracellular domains of the human integrin αv, β1, β3, and β4
subunits were kindly provided by Dr. Junichi Takagi (Institute for
Protein Research, Osaka University) (Takagi et al, 2001, 2002a, b). An
expression vector for the extracellular domains of human integrin
α5 was constructed in a similar manner to those of other integrin α
subunits (Nishiuchi et al, 2006; Sato-Nishiuchi et al, 2012; Jeong et al,
2013). An expression vector for the extracellular domain of human
integrin β5 was prepared using a cDNA amplified from RNA
extracted from T98G human glioblastoma cells. Expression vectors
Laminin γ1 EQ knock-in mice Kiyozumi et al. https://doi.org/10.26508/lsa.201800064 vol 1 | no 5 | e201800064 6 of 11
Figure 4. Generation of γ1 EQ conditional knock-in
mice.
(A) Schematic representation of the generation of
Lamc1cEQ. The open boxes represent exons. The protein
coding sequences are indicated in gray. The targeting
construct was designed to replaceWT exon 28 encoding
Glu at residue 1,605 with a floxed exon 28 followed by
a mutated exon 28 encoding Gln at residue 1,605. The
probes used for Southern blotting are indicated by bold
lines. (B) Southern blot analyses of genomic DNA from
WT, Lamc1cEQ(neo)/+, and Lamc1cEQ/+ offspring after
digestion with SexAI and PacI. The detection of 9.0 and
7.4 kbp fragments with probe 1 and probe 2,
respectively, in the Lamc1cEQ(neo)/+ lanes indicates
occurrence of the expected homologous
recombination. The detection of a 7.4 kbp fragment with
probe 1 in the Lamc1cEQ/+ lane indicates that the
neomycin-resistance gene has been removed from the
Lamc1cEQ(neo) allele by the Cre-loxP system. (C)
Genotypes of offspring obtained from Lamc1cEQ/+
intercrosses. (D–I) Histochemical analyses of Lamc1cEQ/cEQ
(D–F) and Tie2-cre;Lamc1cEQ/cEQ (G–I) retinas. (D, G) In
situ binding of recombinant integrin α3β1 (magenta) to
frozen retinal sections. (E, H) Counterstaining of vascular
BM with an anti–laminin-α5 antibody (green). Merged
images with nuclear staining (blue) are also shown
(F and I). Retinal vasculatures are indicated by filled
(Lamc1cEQ/cEQ) and open (Tie2-cre;Lamc1cEQ/cEQ)
arrowheads. Bars, 50 μm. (J) Genotypes of offspring
obtained from mating between Lamc1cEQ/+ female and
Tie2-cre;Lamc1cEQ/+ male mice. Only Lamc1cEQ/cEQ and
Tie2-cre;Lamc1cEQ/cEQmice are shown. S, SexAI restriction
site; P, PacI restriction site; TK, thymidine kinase gene.
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for recombinant human vitronectin with an N-terminal FLAG tag
and the C-terminal fragment of mouse polydom were prepared as
described (Sato-Nishiuchi et al, 2012; Ozawa et al, 2016).
Expression and purification of recombinant proteins
Recombinant human laminin-111, laminin-511, and their EQmutants
were produced using a FreeStyle 293 Expression System (Thermo
Fisher Scientific) as described (Ido et al, 2004). The conditioned
media were passed over ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich).
After washing with 20 mM Tris-buffered saline without divalent
cations (TBS), bound proteins were eluted with 100 μg/ml FLAG
peptide (Sigma-Aldrich) and dialyzed against TBS. Purified proteins
were verified by 4% SDS–PAGE under reducing conditions (Fig S1).
Other recombinant proteins (integrin α1β1, α2β1, α3β1, α6β1, α7x1β1,
α7x2β1, α9β1, αvβ3, αvβ5, and α5β1, and vitronectin and C-terminal
fragment of polydom) were produced using the FreeStyle 293 Ex-
pression System and purified on ANTI-FLAG M2 Affinity Gel as
described above. Protein concentrations were determined with
a BCA protein assay kit (Thermo Fisher Scientific) using BSA as
a standard.
Laminin secretion assay
Recombinant human laminin-111, laminin-511, and their EQmutants
were produced using the FreeStyle 293 Expression System as de-
scribed above. Conditioned media were recovered at 3 d after
transfection and applied to SDS–PAGE and subsequent Western
blot analyses.
Western blotting
E7.5 embryos were lysed in 20 μl of SDS–PAGE sample buffer under
nonreducing conditions. Purified laminins were prepared as
samples for SDS–PAGE under reducing conditions. Conditioned
media of human 293 cells were mixed with equal amounts of 2×
SDS–PAGE sample buffer under nonreducing conditions. Proteins
were separated by 4% SDS–PAGE and transferred onto nitrocel-
lulose membranes. The membranes were immunoblotted with the
indicated primary Abs and goat anti-rabbit or anti-mouse IgG
secondary antibodies conjugated with HRP (Jackson Immuno-
Research Laboratories). The bound primary antibody was visualized
with an Amersham ECL PrimeWestern blotting detection reagent kit
(GE Healthcare).
Integrin binding assays
Solid-phase assays for binding of integrins to laminins, collagens,
vitronectin, and polydom were carried out as described (Taniguchi
et al, 2017). Briefly, 96-well microtiter plates were coated with
recombinant proteins (laminins, vitronectin, and polydom, 5 nM;
collagens, 10 μg/ml) overnight at 4°C, blocked with 3% BSA for 1 h at
room temperature, and incubated with 30 nM integrins for 3 h at
room temperature in the presence of 1 mMMn2+. Bound integrins were
detected after sequential incubations with biotinylated rabbit
anti-Velcro pAb and HRP-conjugated streptavidin. The amounts of
recombinant laminins, vitronectin, and polydom adsorbed on the
plates were quantified by enzyme-linked immunosorbent assays using
an anti-FLAG M2 mAb to confirm equality of the adsorbed proteins.
Mice
The B6.Cg-Tg(CAG-cre)CZ-MO2Osb mouse strain expressing Cre-
recombinase under the CAG promoter (BRC No. 01828) was pro-
vided by the RIKEN BioResource Center with support from the
National BioResource Project of the Ministry of Education, Culture,
Sports, Science and Technology, Japan. The B6-Tg(CAG-FLPe)36
mouse strain expressing Flp-recombinase under the CAG pro-
moter (BRC No. 01834) (Kanki et al, 2006) was also provided by RIKEN
BioResource Center with support from the National BioResource
Project of the Ministry of Education, Culture, Sports, Science and
Technology, Japan. The B6.Cg-Tg(Tek-cre)1Ywa/J (Tie2-cre) mouse
strain expressing Cre-recombinase under the Tek (Tie2) promoter
(Kisanuki et al, 2001) was provided by Jackson Laboratory.
To generate Lamc1EQ knock-in mice, a knock-in vector was
constructed to include the 2-kb upstream Lamc1 genomic se-
quence, a neomycin-resistance gene sandwiched by loxP se-
quences, the 5-kb downstream Lamc1 genomic sequence, and
a thymidine kinase gene, as shown schematically in Fig 2A. To
introduce the γ1 EQ mutation, the 5-kb genomic sequence was
point-mutated by overlap-extension PCR. The knock-in vector was
introduced into strain 129 mouse ES cells. The resulting targeted
clones were verified by PCR and Southern blotting and injected into
C57Bl/6 blastocysts to obtain chimeric mice. Male chimeric mice
that transmitted the mutated Lamc1 gene through the germline
were crossed with C57Bl/6 female mice (Japan SLC) to generate
Lamc1EQ(Neo) mice. The Lamc1EQ(Neo)/+ heterozygotes were crossed
with B6.Cg-Tg(CAG-cre)CZ-MO2Osb mice to obtain Lamc1EQ/+ het-
erozygotes, in which the neomycin-resistance gene was removed.
The Lamc1EQ/+ heterozygotes were crossed to obtain Lamc1EQ/EQ
homozygotes and WT littermates. E0.5 was defined as noon on the
day of plug detection.
To generate Lamc1cEQmice, a knock-in vector was constructed as
follows. The vector included the 2-kb upstream Lamc1 genomic
sequence, a neomycin-resistance gene sandwiched by loxP se-
quences, the 5-kb downstream Lamc1 genomic sequence, and
a thymidine kinase gene, as shown schematically in Fig 4A. To
introduce the γ1 EQ mutation, the 5-kb genomic sequence was
point-mutated by overlap-extension PCR. The knock-in vector was
introduced into strain 129 mouse ES cells. The resulting targeted
clones were verified by PCR and Southern blotting, and injected into
C57Bl/6 blastocysts to obtain chimeric mice. Male chimeric mice
that transmitted the mutated Lamc1 gene through the germline
were crossed with C57Bl/6 female mice to generate Lamc1cEQ(Neo)
mice. The resulting Lamc1cEQ(Neo)/+ heterozygotes were crossed with
B6-Tg(CAG-FLPe)36 mice to obtain Lamc1cEQ/+ heterozygotes in
which the neomycin-resistance gene was removed. Lamc1cEQ/+
heterozygotes were crossed to obtain Lamc1cEQ/cEQ homozygotes
andWT littermates. Lamc1cEQ/+ heterozygotes werematedwith Tie2-
cre mice to obtain Lamc1cEQ/+;Tie2-cre mice. Lamc1cEQ/+;Tie2-cre
male mice were mated with Lamc1cEQ/+ mice to obtain Lamc1cEQ/cEQ;
Tie2-cre and control Lamc1cEQ/cEQ littermates.
The mice were kept in a specific pathogen-free environment
under stable conditions of temperature and light (lights ON at 08:00
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and OFF at 20:00). All mouse experiments were performed in
compliance with our institutional guidelines and were approved by
the Animal Care Committee of Osaka University.
Ex vivo blastocyst culture
E3.5 blastocysts were flushed from the uterus with flushing-holding
medium (Lawitts & Biggers, 1993), washed with potassium simplex
optimization medium (Lawitts & Biggers, 1993), and cultured in
a hanging drop of potassium simplex optimization medium at 37°C
for 48 h under 5% CO2.
Genotyping
Genomic DNAs were extracted with DirectPCR Lysis Reagent (Viagen
Biotech) at 55°C overnight and then heat-denatured at 95°C for
10 min.
The genotypes of Lamc1EQ postnatal mice and whole-mount
embryos were determined by genomic PCR using the primer pair
59-AAGCAGGAGGCAGCCATCATGGACT-39 and 59-GGAAGATGCCGTGACT-
TCAGGCAAA-39. WT DNA and Lamc1EQ DNA both gave PCR products of
approximately 400 bp. The PCR products were digested with TaqI
and separated by 1.8% agarose gel electrophoresis. Although the
PCR product derived from the WT allele was digested into bands of
280 and 120 bp, the PCR product derived from the Lamc1EQ allele
remained undigested because the γ1 EQ mutation abolished the
TaqI site.
Because it is difficult to isolate embryonic tissues without
contamination by surrounding maternal tissues, the genotypes of
sectioned embryos were determined by their integrin-binding
activity in situ (Kiyozumi et al, 2014). For sectioned E5.5–E7.5 em-
bryos, the genotypes were determined by in situ binding of
recombinant integrin α7x2β1. Embryos that showed integrin α7x2β1
binding to anti-laminin immunoreactive sites were genotyped as
WT or Lamc1EQ/+, whereas those that did not show α7x2β1 binding
were genotyped as Lamc1EQ/EQ. As Lamc1EQ/+ mice appeared nor-
mal, we did not distinguish Lamc1EQ/+ from WT after genotyping by
in situ integrin binding and their genotypes are presented as WT or
Lamc1EQ/+ in the relevant figures.
The genotypes of Lamc1cEQ mice were determined by genomic
PCR using the primer pair 59-TTACCAAGTCACCTTCTTCAGCATAAGCGA-
39 and 59-GTACATGCGTGTCTGCATGAATGCCATA-39. The sizes of the
PCR products from theWT and Lamc1cEQ alleles were 234 and 423 bp,
respectively.
The genotypes of the Tie2-cre transgene were determined by
genomic PCR using the primer pair 59-GTTTCACTGGTTATGCGGCGG-39
and 59-TTCCAGGGCGCGAGTTGATAG-39. The size of the PCR product
was 450 bp.
In situ integrin binding
In situ integrin binding was performed as described (Kiyozumi et al,
2012, 2014). Frozen sections of mouse embryos were blocked with
blocking buffer (3% BSA, 25 mM Tris–HCl pH 7.4, 100 mM NaCl, and
1 mM MnCl2) for 30 min at room temperature, and then incubated
with 3 μg/ml of recombinant integrin α7x2β1 and rat anti-laminin-
α1 mAb (5B7-H1) in blocking buffer at 4°C overnight. The sections
were washed three times with wash buffer (25 mM Tris–HCl pH 7.4,
100 mM NaCl, and 1 mM MnCl2) for 10 min at room temperature, and
incubated with 0.5 μg/ml of rabbit anti-Velcro pAb in blocking
buffer at room temperature for 2 h. After washing with wash buffer,
the sections were incubated with Alexa 488-conjugated goat anti-
rabbit IgG and Cy3-conjugated anti-rat IgG. The nuclei were stained
with Hoechst 33342. After washing with wash buffer, the sections
were mounted in PermaFluor (Thermo Scientific Shandon) and
visualized with an LSM510 laser confocal microscope (Carl Zeiss).
Immunofluorescence
Whole-mount immunofluorescence of blastocysts was performed
as follows: Blastocysts were fixed in 4% paraformaldehyde in PBS at
4°C for 10 min. The fixed blastocysts were washed with PBS, per-
meabilized with 0.1% Triton X-100 in PBS at 4°C for 10 min, and
incubated with a rabbit anti-laminin pAb and rat anti-perlecan mAb
or rat anti-mouse integrin-α6 mAb (GoH3) diluted in 0.1% Tween-
20/PBS (TPBS) at 4°C overnight. The embryos were then washed
three times with TPBS for 10 min, and incubated with Alexa 546-
conjugated goat anti-rabbit IgG and Alexa 488-conjugated goat
anti-rat IgG. The nuclei were stained with Hoechst 33342 for 2 h.
After three washes with TPBS for 10 min, the blastocysts were
placed in a small drop of PBS covered with mineral oil on a cov-
erslip, and visualized under the LSM510 confocal microscope.
Immunofluorescence of sectioned tissues was also performed.
Frozen sections of mouse embryos were fixed in 4% para-
formaldehyde in PBS at 4°C for 10min, blocked with 3%BSA/TPBS at
4°C for 30 min, and incubated at 4°C overnight with the following
antibodies diluted in 3% BSA/TPBS: mixture of rabbit anti-laminin
pAb and rat anti–cytokeratin-8 mAb (TROMA-I); mixture of rat
anti–laminin-α1 mAb, mouse anti-Cdx2 mAb, and rabbit anti-Oct4
pAb; or mixture of rabbit anti-laminin pAb and rat anti–laminin-α5
mAb (M5N8-C8). The sections were washed three times with TPBS
for 10min, and incubated at 4°C for 2 h with the following secondary
antibodies: Alexa 488-conjugated goat anti-rabbit IgG and Alexa
546-conjugated goat anti-rat IgG; or Alexa 405-conjugated goat
anti-rabbit IgG, Alexa 488-conjugated goat anti-rat IgG, and Alexa
546-conjugated goat anti-mouse IgG. The nuclei were stained with
Hoechst 33342 if necessary. After three washes with TPBS for 10 min,
the sections were mounted in PermaFluor and visualized using the
LSM510 laser confocal microscope.
Frozen sections of 8-wk-old mouse retina were air-dried for
30 min at room temperature, fixed with cold acetone at −30°C for
15 min, washed with TBS, blocked with blocking buffer (1% BSA,
25 mM Tris–HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl2) for 30 min at
room temperature, and incubated with 3 μg/ml of recombinant
integrins and specified antibodies in blocking buffer at 4°C over-
night. The sections werewashed three timeswithwash buffer (25mM
Tris–HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl2) for 10 min at room
temperature, and incubated with 0.5 μg/ml of rabbit anti-Velcro pAb
and anti–laminin-α5 mAb in blocking buffer at room temperature for
2 h. After washing with wash buffer, the sections were incubated with
Alexa 488-conjugated goat anti-rabbit IgG and Alexa 546-conjugated
anti-rat IgG. The nuclei were stained with Hoechst 33342. After
washing with wash buffer, the sections were mounted in PermaFluor
and visualized using the LSM510 laser confocal microscope.
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The LSM510 laser confocal microscope was equipped with LD-
Achroplan (20×, NA 0.4) and Plan-Neofluar (10×, NA 0.3; 40×, NA 0.75)
objective lenses at room temperature. The imagingmediumwas air.
The LSM510 PASCAL software (Carl Zeiss) was used for image col-
lection. Each set of stained samples was processed under identical
gain and laser power settings. Each set of obtained images was
processed under identical brightness and contrast settings, which
were adjusted by the LSM image browser (Carl Zeiss) and ImageJ
software (Abràmoff et al, 2004) for clear visualization of BMs. At
least four pairs of sections for mutant mice and their control lit-
termates were examined, and similar results were obtained.
Image analysis
The lengthof theRMwasmeasuredonanti-laminin immunofluorescence-
stained images of E5.5 egg cylinders using ImageJ software (see also
Fig 3P).
Statistical analysis
A normal distribution of data was confirmed by normal quantile–
quantile plot analysis. Effect size, post hoc analyses for actual sta-
tistical power (1−β), and a priori analyses for required sample sizes
under given statistical parameters for two-mean analyses were
determined by G*Power version 3.1.9.2 (Faul et al, 2009). Statistical
significance was determined by a two-tailed Welch’s t test using
Microsoft Excel for Mac 2011. A value of P < 0.05 was considered to
indicate a statistically significant difference. P-values are only shown
in figures where the actual statistical power was ≥0.8.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800064.
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